Literature DB >> 346269

The natural antibody response to E. coli includes antibodies of the IgD class.

H F Sewell, L Chambers, V Maxwell, J B Matthews, R Jefferis.   

Abstract

Antibodies to E. coli of the IgM, IgG and IgA class are readily demonstrable in normal human serum. Using the sensitive red cell-linked antigen-antiglobulin system, it has been demonstrated that antibodies of the IgD class are also part of this normal response. The IgD antibody titre is low and often could only be demonstrated in partially purified IgD preparations. The availability of purified IgD paraproteins and their Fabdelta and Fcdelta fragments, as well as antisera specific for these fragments, allowed the necessary critical specificity controls to be performed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 346269      PMCID: PMC1541194     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  [Method permitting the combined study of the electrophoretic and the immunochemical properties of protein mixtures; application to blood serum].

Authors:  P GRABAR; C A WILLIAMS
Journal:  Biochim Biophys Acta       Date:  1953-01

2.  Autoantibodies to colon in rats and human ulcerative colitis: cross reactivity with Escherichia coli O:14 antigen.

Authors:  P Perlmann; S Hammarström; R Lagercrantz; D Campbell
Journal:  Proc Soc Exp Biol Med       Date:  1967-07

3.  IgD on the surface of peripheral blood lymphocytes of the human newborn.

Authors:  D S Rowe; K Hug; W P Faulk; J N McCormick; H Gerber
Journal:  Nat New Biol       Date:  1973-04-04

4.  Kappa-chain deficiency.

Authors:  G M Bernier; J R Gunderman; F B Ruymann
Journal:  Blood       Date:  1972-12       Impact factor: 22.113

5.  A study of antibody responses by radioimmunodiffusion with demonstration of gamma D antigen-binding activity in four sera.

Authors:  D C Heiner; B Rose
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

6.  Light chain types in plasma cells that produce IgD.

Authors:  B Pernis; M Governa; D S Rowe
Journal:  Immunology       Date:  1969-05       Impact factor: 7.397

7.  Structure and biological functions of human IgD. VII. IgD antinuclear antibodies in sera of patients with autoimmune disorders.

Authors:  M I Luster; G A Leslie; E J Bardana
Journal:  Int Arch Allergy Appl Immunol       Date:  1976

8.  Studies of human IgD myeloma proteins. Proteolytic digestion patterns.

Authors:  R Jefferis; J B Mathews
Journal:  Immunochemistry       Date:  1977-03

9.  IgD antibody to insuin.

Authors:  M Devey; C J Sanderson; D Carter; R R Coombs
Journal:  Lancet       Date:  1970-12-19       Impact factor: 79.321

10.  Occurrence of surface IgM, IgD, and free light chains of human lymphocytes.

Authors:  S M Fu; R J Winchester; H G Kunkel
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Immunoglobulin D: properties, measurement, and clinical relevance.

Authors:  A O Vladutiu
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 2.  New insights into the enigma of immunoglobulin D.

Authors:  Kang Chen; Andrea Cerutti
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  The truth on IgD in the ploy of immune surveillance and inflammation.

Authors:  Donato Rigante
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

4.  Changes in serum IgD in cigarette smokers.

Authors:  S L Bahna; D C Heiner; B A Myhre
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

5.  Human immunoglobulin D in colostrum, saliva and amniotic fluid.

Authors:  H F Sewell; J B Matthews; V Flack; R Jefferis
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

6.  IgM and IgD concentrations in the serum and secretions of children with selective IgA deficiency.

Authors:  A Plebani; E Mira; E Mevio; V Monafo; L D Notarangelo; A Avanzini; A G Ugazio
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

7.  The clinical condition of IgA-deficient patients is related to the proportion of IgD- and IgM-producing cells in their nasal mucosa.

Authors:  P Brandtzaeg; G Karlsson; G Hansson; B Petruson; J Björkander; L A Hanson
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.